APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glipizide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glipizide Industry Growth and Trends Forecast to 2032

Report ID 173995340122 December 2025104 pages

Choose your research edition.

Industry ResearchGlipizide Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Glipizide Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Glipizide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glipizide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glipizide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Glipizide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glipizide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glipizide include CCPC, TEVA, Lukang Pharma, United Laboratories, Jumpcan, Pfizer, PIDI, Disha Pharma and Jingfeng Zhiyao, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glipizide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glipizide market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glipizide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glipizide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glipizide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glipizide Market by Company

CCPC

TEVA

Lukang Pharma

United Laboratories

Jumpcan

Pfizer

PIDI

Disha Pharma

Jingfeng Zhiyao

Yashica Pharma

Apotex

Glipizide Segment by Type

Glipizide Tablets

Glipizide Sustained Release Tablets

Others

Glipizide Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Glipizide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glipizide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glipizide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glipizide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glipizide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glipizide Tablets Table 2. Major Company of Glipizide Sustained Release Tablets Table 3. Major Company of Others Table 4. Global Glipizide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Glipizide Sales by Type (2021-2026) & (kg) Table 6. Global Glipizide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Glipizide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Glipizide Sales Market Share in Value by Type (2021-2026) Table 9. Global Glipizide Price by Type (2021-2026) & (US$/kg) Table 10. Global Glipizide Sales by Type (2027-2032) & (kg) Table 11. Global Glipizide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Glipizide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Glipizide Sales Market Share in Value by Type (2027-2032) Table 14. Global Glipizide Price by Type (2027-2032) & (US$/kg) Table 15. North America Glipizide Sales by Type (2021-2026) & (kg) Table 16. North America Glipizide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Glipizide Sales by Type (2021-2026) & (kg) Table 18. Europe Glipizide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Glipizide Sales by Type (2021-2026) & (kg) Table 20. Asia-Pacific Glipizide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Glipizide Sales by Type (2021-2026) & (kg) Table 22. Latin America Glipizide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Glipizide Sales by Type (2021-2026) & (kg) Table 24. Middle East and Africa Glipizide Sales by Type (2021-2026) & (US$ Million) Table 25. Glipizide Industry Trends Table 26. Glipizide Industry Drivers Table 27. Glipizide Industry Opportunities and Challenges Table 28. Glipizide Industry Restraints Table 29. Global Glipizide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Glipizide Revenue Market Share by Company (2021-2026) Table 31. Global Glipizide Sales by Company (2021-2026) & (kg) Table 32. Global Glipizide Sales Share by Company (2021-2026) Table 33. Global Glipizide Market Price by Company (2021-2026) & (US$/kg) Table 34. Global Glipizide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Glipizide Major Company Production Sites and Headquarters Table 36. Global Glipizide Company, Product Type & Application Table 37. Global Glipizide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Glipizide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Glipizide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Glipizide Sales by Region (2021-2026) & (kg) Table 42. Global Glipizide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Glipizide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Glipizide Sales Market Share in Value by Region (2021-2026) Table 45. Global Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 46. Global Glipizide Sales by Region (2027-2032) & (kg) Table 47. Global Glipizide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Glipizide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Glipizide Sales Market Share in Value by Region (2027-2032) Table 50. Global Glipizide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 51. Global Glipizide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Glipizide Sales by Application (2021-2026) & (kg) Table 53. Global Glipizide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Glipizide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Glipizide Sales Market Share in Value by Application (2021-2026) Table 56. Global Glipizide Price by Application (2021-2026) & (US$/kg) Table 57. Global Glipizide Sales by Application (2027-2032) & (kg) Table 58. Global Glipizide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Glipizide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Glipizide Sales Market Share in Value by Application (2027-2032) Table 61. Global Glipizide Price by Application (2027-2032) & (US$/kg) Table 62. North America Glipizide Sales by Application (2021-2026) & (kg) Table 63. North America Glipizide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Glipizide Sales by Application (2021-2026) & (kg) Table 65. Europe Glipizide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Glipizide Sales by Application (2021-2026) & (kg) Table 67. Asia-Pacific Glipizide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Glipizide Sales by Application (2021-2026) & (kg) Table 69. Latin America Glipizide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Glipizide Sales by Application (2021-2026) & (kg) Table 71. Middle East and Africa Glipizide Sales by Application (2021-2026) & (US$ Million) Table 72. CCPC Company Information Table 73. CCPC Business Overview Table 74. CCPC Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. CCPC Glipizide Product Portfolio Table 76. CCPC Recent Development Table 77. TEVA Company Information Table 78. TEVA Business Overview Table 79. TEVA Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. TEVA Glipizide Product Portfolio Table 81. TEVA Recent Development Table 82. Lukang Pharma Company Information Table 83. Lukang Pharma Business Overview Table 84. Lukang Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 85. Lukang Pharma Glipizide Product Portfolio Table 86. Lukang Pharma Recent Development Table 87. United Laboratories Company Information Table 88. United Laboratories Business Overview Table 89. United Laboratories Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 90. United Laboratories Glipizide Product Portfolio Table 91. United Laboratories Recent Development Table 92. Jumpcan Company Information Table 93. Jumpcan Business Overview Table 94. Jumpcan Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 95. Jumpcan Glipizide Product Portfolio Table 96. Jumpcan Recent Development Table 97. Pfizer Company Information Table 98. Pfizer Business Overview Table 99. Pfizer Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 100. Pfizer Glipizide Product Portfolio Table 101. Pfizer Recent Development Table 102. PIDI Company Information Table 103. PIDI Business Overview Table 104. PIDI Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 105. PIDI Glipizide Product Portfolio Table 106. PIDI Recent Development Table 107. Disha Pharma Company Information Table 108. Disha Pharma Business Overview Table 109. Disha Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 110. Disha Pharma Glipizide Product Portfolio Table 111. Disha Pharma Recent Development Table 112. Jingfeng Zhiyao Company Information Table 113. Jingfeng Zhiyao Business Overview Table 114. Jingfeng Zhiyao Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 115. Jingfeng Zhiyao Glipizide Product Portfolio Table 116. Jingfeng Zhiyao Recent Development Table 117. Yashica Pharma Company Information Table 118. Yashica Pharma Business Overview Table 119. Yashica Pharma Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 120. Yashica Pharma Glipizide Product Portfolio Table 121. Yashica Pharma Recent Development Table 122. Apotex Company Information Table 123. Apotex Business Overview Table 124. Apotex Glipizide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 125. Apotex Glipizide Product Portfolio Table 126. Apotex Recent Development Table 127. North America Glipizide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 128. North America Glipizide Sales by Country (2021-2026) & (kg) Table 129. North America Glipizide Sales Market Share by Country (2021-2026) Table 130. North America Glipizide Sales Forecast by Country (2027-2032) & (kg) Table 131. North America Glipizide Sales Market Share Forecast by Country (2027-2032) Table 132. North America Glipizide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Glipizide Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Glipizide Market Share by Country (2021-2026) Table 135. North America Glipizide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Glipizide Market Share Forecast by Country (2027-2032) Table 137. Europe Glipizide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 138. Europe Glipizide Sales by Country (2021-2026) & (kg) Table 139. Europe Glipizide Sales Market Share by Country (2021-2026) Table 140. Europe Glipizide Sales Forecast by Country (2027-2032) & (kg) Table 141. Europe Glipizide Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Glipizide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Glipizide Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Glipizide Market Share by Country (2021-2026) Table 145. Europe Glipizide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Glipizide Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Glipizide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Glipizide Sales by Country (2021-2026) & (kg) Table 149. Asia-Pacific Glipizide Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Glipizide Sales Forecast by Country (2027-2032) & (kg) Table 151. Asia-Pacific Glipizide Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Glipizide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Glipizide Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Glipizide Market Share by Country (2021-2026) Table 155. Asia-Pacific Glipizide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Glipizide Market Share Forecast by Country (2027-2032) Table 157. Latin America Glipizide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 158. Latin America Glipizide Sales by Country (2021-2026) & (kg) Table 159. Latin America Glipizide Sales Market Share by Country (2021-2026) Table 160. Latin America Glipizide Sales Forecast by Country (2027-2032) & (kg) Table 161. Latin America Glipizide Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Glipizide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Glipizide Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Glipizide Market Share by Country (2021-2026) Table 165. Latin America Glipizide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Glipizide Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Glipizide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Glipizide Sales by Country (2021-2026) & (kg) Table 169. Middle East and Africa Glipizide Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Glipizide Sales Forecast by Country (2027-2032) & (kg) Table 171. Middle East and Africa Glipizide Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Glipizide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Glipizide Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Glipizide Market Share by Country (2021-2026) Table 175. Middle East and Africa Glipizide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Glipizide Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Glipizide Distributors List Table 180. Glipizide Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Glipizide Image Figure 2. Global Glipizide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glipizide Market Size (2021-2032) & (US$ Million) Figure 4. Global Glipizide Sales (2021-2032) & (kg) Figure 5. Glipizide Tablets Image Figure 6. Global Glipizide Tablets Sales YoY Growth (2021-2032) & (kg) Figure 7. Glipizide Sustained Release Tablets Image Figure 8. Global Glipizide Sustained Release Tablets Sales YoY Growth (2021-2032) & (kg) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (kg) Figure 11. Global Glipizide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Glipizide Market Share by Type 2025 VS 2032 Figure 13. North America Glipizide Sales Market Share in Volume by Type in 2025 Figure 14. North America Glipizide Sales Market Share in Value by Type in 2025 Figure 15. Europe Glipizide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Glipizide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Glipizide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Glipizide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Glipizide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Glipizide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Glipizide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Glipizide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Glipizide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 31. Global Glipizide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Glipizide Market Share by Application 2025 VS 2032 Figure 33. North America Glipizide Sales Market Share in Volume by Application in 2025 Figure 34. North America Glipizide Sales Market Share in Value by Application in 2025 Figure 35. Europe Glipizide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Glipizide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Glipizide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Glipizide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Glipizide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Glipizide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Glipizide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Glipizide Sales Market Share in Value by Application in 2025 Figure 43. North America Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. North America Glipizide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Glipizide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Glipizide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Europe Glipizide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Glipizide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Glipizide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Asia-Pacific Glipizide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Glipizide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Glipizide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Latin America Glipizide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Glipizide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Glipizide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Glipizide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 60. Middle East and Africa Glipizide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Glipizide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Glipizide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Glipizide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Glipizide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Glipizide Tablets
  • Glipizide Sustained Release Tablets
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • CCPC
  • TEVA
  • Lukang Pharma
  • United Laboratories
  • Jumpcan
  • Pfizer
  • PIDI
  • Disha Pharma
  • Jingfeng Zhiyao
  • Yashica Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glipizide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glipizide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glipizide Market by Type
  6. 1.3.1 Glipizide Tablets
  7. 1.3.2 Glipizide Sustained Release Tablets
  8. 1.3.3 Others
  9. 1.4 Global Glipizide Market Size by Type
  10. 1.4.1 Global Glipizide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Glipizide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Glipizide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Glipizide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Glipizide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Glipizide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Glipizide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Glipizide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glipizide Industry Trends
  2. 2.2 Glipizide Industry Drivers
  3. 2.3 Glipizide Industry Opportunities and Challenges
  4. 2.4 Glipizide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glipizide Revenue (2021-2026)
  2. 3.2 Global Top Players by Glipizide Sales (2021-2026)
  3. 3.3 Global Top Players by Glipizide Price (2021-2026)
  4. 3.4 Global Glipizide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glipizide Major Company Production Sites & Headquarters
  6. 3.6 Global Glipizide Company, Product Type & Application
  7. 3.7 Global Glipizide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glipizide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glipizide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glipizide Tier 1, Tier 2, and Tier 3
4 Glipizide Regional Status and Outlook
  1. 4.1 Global Glipizide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glipizide Historic Market Size by Region
  3. 4.2.1 Global Glipizide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glipizide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glipizide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glipizide Forecasted Market Size by Region
  7. 4.3.1 Global Glipizide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glipizide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glipizide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glipizide by Application
  1. 5.1 Glipizide Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Glipizide Market Size by Application
  6. 5.2.1 Global Glipizide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Glipizide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Glipizide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Glipizide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Glipizide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Glipizide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Glipizide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Glipizide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CCPC
  2. 6.1.1 CCPC Company Information
  3. 6.1.2 CCPC Business Overview
  4. 6.1.3 CCPC Glipizide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CCPC Glipizide Product Portfolio
  6. 6.1.5 CCPC Recent Developments
  7. 6.2 TEVA
  8. 6.2.1 TEVA Company Information
  9. 6.2.2 TEVA Business Overview
  10. 6.2.3 TEVA Glipizide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TEVA Glipizide Product Portfolio
  12. 6.2.5 TEVA Recent Developments
  13. 6.3 Lukang Pharma
  14. 6.3.1 Lukang Pharma Company Information
  15. 6.3.2 Lukang Pharma Business Overview
  16. 6.3.3 Lukang Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lukang Pharma Glipizide Product Portfolio
  18. 6.3.5 Lukang Pharma Recent Developments
  19. 6.4 United Laboratories
  20. 6.4.1 United Laboratories Company Information
  21. 6.4.2 United Laboratories Business Overview
  22. 6.4.3 United Laboratories Glipizide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 United Laboratories Glipizide Product Portfolio
  24. 6.4.5 United Laboratories Recent Developments
  25. 6.5 Jumpcan
  26. 6.5.1 Jumpcan Company Information
  27. 6.5.2 Jumpcan Business Overview
  28. 6.5.3 Jumpcan Glipizide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jumpcan Glipizide Product Portfolio
  30. 6.5.5 Jumpcan Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Glipizide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Glipizide Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 PIDI
  38. 6.7.1 PIDI Company Information
  39. 6.7.2 PIDI Business Overview
  40. 6.7.3 PIDI Glipizide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PIDI Glipizide Product Portfolio
  42. 6.7.5 PIDI Recent Developments
  43. 6.8 Disha Pharma
  44. 6.8.1 Disha Pharma Company Information
  45. 6.8.2 Disha Pharma Business Overview
  46. 6.8.3 Disha Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Disha Pharma Glipizide Product Portfolio
  48. 6.8.5 Disha Pharma Recent Developments
  49. 6.9 Jingfeng Zhiyao
  50. 6.9.1 Jingfeng Zhiyao Company Information
  51. 6.9.2 Jingfeng Zhiyao Business Overview
  52. 6.9.3 Jingfeng Zhiyao Glipizide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jingfeng Zhiyao Glipizide Product Portfolio
  54. 6.9.5 Jingfeng Zhiyao Recent Developments
  55. 6.10 Yashica Pharma
  56. 6.10.1 Yashica Pharma Company Information
  57. 6.10.2 Yashica Pharma Business Overview
  58. 6.10.3 Yashica Pharma Glipizide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yashica Pharma Glipizide Product Portfolio
  60. 6.10.5 Yashica Pharma Recent Developments
  61. 6.11 Apotex
  62. 6.11.1 Apotex Company Information
  63. 6.11.2 Apotex Business Overview
  64. 6.11.3 Apotex Glipizide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Apotex Glipizide Product Portfolio
  66. 6.11.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Glipizide Sales by Country
  2. 7.1.1 North America Glipizide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glipizide Sales by Country (2021-2026)
  4. 7.1.3 North America Glipizide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glipizide Market Size by Country
  6. 7.2.1 North America Glipizide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glipizide Market Size by Country (2021-2026)
  8. 7.2.3 North America Glipizide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glipizide Sales by Country
  2. 8.1.1 Europe Glipizide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glipizide Sales by Country (2021-2026)
  4. 8.1.3 Europe Glipizide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glipizide Market Size by Country
  6. 8.2.1 Europe Glipizide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glipizide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glipizide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glipizide Sales by Country
  2. 9.1.1 Asia-Pacific Glipizide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glipizide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glipizide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glipizide Market Size by Country
  6. 9.2.1 Asia-Pacific Glipizide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glipizide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glipizide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glipizide Sales by Country
  2. 10.1.1 South America Glipizide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glipizide Sales by Country (2021-2026)
  4. 10.1.3 South America Glipizide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glipizide Market Size by Country
  6. 10.2.1 South America Glipizide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glipizide Market Size by Country (2021-2026)
  8. 10.2.3 South America Glipizide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glipizide Sales by Country
  2. 11.1.1 Middle East and Africa Glipizide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glipizide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glipizide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glipizide Market Size by Country
  6. 11.2.1 Middle East and Africa Glipizide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glipizide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glipizide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glipizide Value Chain Analysis
  2. 12.1.1 Glipizide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glipizide Production Mode & Process
  7. 12.2 Glipizide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glipizide Distributors
  10. 12.2.3 Glipizide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst